In the present study, we identified PVT1 as a potential chemotherapeutic target of gemcitabine and demonstrated that gemcitabine triggered PVT1 processing into miRNAs by regulating the function of the microprocessor in PC cells. Here, PVT1 is linked to pachyonychia congenita.